Testing Cosmetic Flashcards

(139 cards)

1
Q

SAFETY OF THE COSMETIC PRODUCTS

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cosmetics should not ….. affect the human

health

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

toxicological testing is needed

A

/

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

EXAMPLES OF REGULATORY REQUIREMENTS FOR THE USE OF HUMANS IN RESEARCH

A

/

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The Declaration of Helsinki (1964).

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Good Clinical Practice (GCP) for trials on medicinal products in the EU.

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

National regulations regarding human studies.

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The health and welfare of subjects has the priority and must be highly protected.

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Historically most toxicological
data are generated by testing
on …

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Safety in animals does not

mean safety in humans

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Toxicity in animals does not

mean toxicity in humans

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

…… testing may have limited predictive value

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

vitro techniques, cell culture, tissue culture etc. )

A

M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

…. studies (and alternative techniques) are used to show that the substance being tested is expected to have high degree of safety

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Confirmatory safety testing in …. may be necessary

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Confirmatory tests in humans should not be expected to cause ….. toxicity

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

TESTING FOR IRRITANT ACTION

• Two steps are followed:

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

EVALUATION OF IRRITATION

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Consumer market surveillance

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Ingredient or mixture should be tested at ….. concentration

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Animals and in vitro techniques are used to prove

the ….. irritation potential

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Skin tolerability of the ingredient can be

confirmed by testing in …

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

TESTS USED TO EVALUATE IRRITATION

Type:

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Open patch test

A

I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Closed patch test
J
26
Single and repeated exposure tests
I
27
The choice of the test is based on the
J
28
This test involves application of the ingredient (diluted or undiluted) under investigation on the يشب هيطغا ام و هطحا skin (without occlusion) for a period between 15 min to 24 hr
M
29
This test involves application of the ingredient under investigation (diluted or undiluted) under occlusive chamber for 24 - 48 hr
H
30
The test involves repeated application of the ingredient under investigation to the same area of the skin 1 - 7 times a week for 1-5 weeks (based مادختسلا ةتقيرط بسح ىلع on the expected use pattern)
J
31
EVALUATION OF THE IRRITATION
M
32
Newer techniques such as measuring the
J
33
..... develops after exposure of a sensitized individual to a contact allergen
K
34
Contact allergen (haptens, low MW molecules) bind to skin component
J
35
The hapten-protein conjugate function as an ...
H
36
This antigen is presented to the B-cells to
I
37
When a sensitized individual (with antibodies against the hapten) is exposed to the hapten again, ......is developed.
N
38
ANIMAL ASSAYS FOR SENSITIZING ACTION
I
39
Guinea pig assay
M
40
The animal are treated with the test | substance (by intra-dermal injection or patch )
J
41
The animal develop specific sensitization in the | following ...... if the substance is sensitizer
K
42
After a period, the animal is challenged with a .... of the test substance. more response
K
43
If the animal develops a response to the | challenge, the animal is considered......
L
44
The Guinea Pig Maximization Test
K
45
The Buehler Test
I
46
It includes both intra-dermal and topical induction | and closed challenge
J
47
``` Highly sensitive method Widely used ( give valid result ) ```
K
48
It uses repeated closed topical induction and | closed challenge
U
49
Less sensitive test
J
50
THE MOUSE ASSAY
J
51
The Local Lymph Node Assay (LLNA):
U
52
alternative method to the Guinea pig test
U
53
involves application of the test substance on the | ear of the mouse.
U
54
The response is measured by the degree of | .....
K
55
Shorter test duration
U
56
Objective end point
U
57
Utilizes less test substance
U
58
HUMAN ASSAYS
I
59
A single induction single challenge patch test | Schwartz-Peck Test
J
60
Human Repeated Insult Patch Test (HRIPT)
U
61
Human Maximization Test
U
62
The performance of the different tests | depends on a number of factors
U
63
Ten induction patches are applied on different skin | sites for 24 hr every other day
H
64
After 2 weeks of the last induction patch a | challenge patch is applied for 24 hr
U
65
CONCERNS REGARDING THE USE OF HUMANS IN SENSITIZATION TESTING
H
66
Human sensitization tests are .... consuming and | very ...
,
67
Ingredients identified as sensitizers in animal | studies .... tested in humans
L
68
The volunteers are at risk of developing adverse | effects
J
69
The animal tests used to evaluate the cutaneous | sensitization potential is reliable for a ...
.
70
The animal assays performance may not be as | reliable for a .....
.
71
PROBLEMS ASSOCIATED WITH THE USE OF COSMETICS AND SKIN CARE PRODUCTS
K
72
The reactions depend on the condition of the skin ....
L
73
Contact Dermatitis
,
74
Contact Urticarial Syndrome
L
75
is a general term that describes an | inflammation of the skin
L
76
results from direct contact | with one of many irritants or allergens
K
77
The most common skin irritants include
K
78
Acids
I
79
alkalies
J
80
detergents
U
81
solvents
J
82
bath soap
I
83
make-up removers,
I
84
shampoos
J
85
antiperspirants
J
86
permanent hair- | waving solutions.
I
87
Repeated exposure to weak irritants (water, detergents, abrasive dusts etc.) can have cumulative effect and can cause....
L
88
is caused by reaction between the | body’s immune system and the allergen.
K
89
It takes .......for the body to become sensitized after the initial exposure to the allergen.
M
90
This explains why some individuals can become allergic to a substance after using for weeks without problems.
K
91
COMMON CAUSES OF ALLERGIC CONTACT DERMATITIS
K
92
Fragrances
K
93
Cinnamic alcohol,
K
94
cinnamic aldehyde,
J
95
musk
J
96
isoeuogenol
J
97
increased pigmentation of the affected skin, photodermatitis, or contact dermatitis
M
98
Unscented doesn’t mean.....
.
99
Those who are allergic to fragrance should look | for “fragrance-free” o....
.
100
Advise individuals to apply perfumes to their | clothes not to their ...
.
101
Advise individuals not to apply .... | perfumes to their skin on sunny days
.
102
Preservatives
L
103
An individual who react to one preservative | doesn’t necessary react to other preservatives
L
104
Parabens
M
105
quarternium 15,
I
106
diazolidinyl urea,
I
107
imidazolidynyl urea
K
108
Toothpaste and mouthwashes
M
109
Bleaching or freckle cream
J
110
Sunscreen containing PABA
J
111
Face powders r
J
112
Lipsticks contain waxes and fats
J
113
cocoa butter
J
114
SYNTHETIC COSMETIC INGREDIENTS TO AVOID
K
115
Imidazolidnyl Urea and Diazolidinyl Urea
K
116
Methyl, ethyl, propyl, and butyl parabens
K
117
Petrolatum
K
118
Propylene glycol
K
119
Polyvinylpyrrolidone (PVP)/polyvinyl acetate (PVA) | copolymer
J
120
Sodium lauryl sulphate
K
121
...... lauryl sulphate is not carcinogenic, but it is usually combined with TEA, and DEA which are carcinogenic. So, it is recommended to add antioxidants Vit C, or Vit A to products containing TEA, or DEA.
M
122
Synthetic colors
K
123
Colors used should be ....
L
124
FD&C Red No.40 (Orange-red)
K
125
DIAGNOSIS OF CONTACT DERMATITIS CAUSED BY COSMETIC PRODUCTS
K
126
This is usually done by ....
J
127
Chemicals are applied to the back in small chambers or in circle of filter paper fixed with adhesive tape
J
128
Patches are left for ....
K
129
SYMPTOMS
L
130
erythema, mild edema, | desquamation, papules)
L
131
TREATMENT
L
132
In acute dermatitis, gauze dipped in water and applied to the lesion for soothing and cooling effect. Apply for ....
.
133
.... can be drained but the top should not be | removed.
P
134
In severe cases, oral corticosteroids (prednisone 60 mg/day) ..... (if not contraindicated)
K
135
........... are not effective in the acute phase, but after the acute phase corticosteroid cream or ointment can be applied ........
L
136
........ are not effective in the allergic | contact dermatitis, but it helps in ....
,
137
Individuals with ICU may require antihistamines | and s.c. epinephrine in severe cases.
M
138
Antihistamines: H1 histamine receptor | antagonist.
K
139
Vasopressors: e.g. epinephrine to treat | anaphylactoid reaction
J